| scholarly article | Q13442814 |
| P50 | author | Joel M Gelfand | Q60659843 |
| P2093 | author name string | Daniel B Shin | |
| Junko Takeshita | |||
| Alexis Ogdie | |||
| P2860 | cites work | Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research | Q28201145 |
| Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor | Q28289854 | ||
| The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies | Q29615686 | ||
| The risk of stroke in patients with psoriasis | Q33831094 | ||
| Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database | Q33951592 | ||
| Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network. | Q34111458 | ||
| Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. | Q34253312 | ||
| Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. | Q34478064 | ||
| Validity of The Health Improvement Network (THIN) for the study of psoriasis. | Q34721703 | ||
| Psoriasis and the risk of pneumonia: a population-based study | Q34777002 | ||
| Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity | Q34945351 | ||
| Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom | Q35753936 | ||
| Use of the UK General Practice Research Database for pharmacoepidemiology | Q35802395 | ||
| Accuracy of pneumonia hospital admissions in a primary care electronic medical record database | Q36020016 | ||
| Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis | Q36321202 | ||
| The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. | Q36602668 | ||
| Prevalence and treatment patterns of psoriatic arthritis in the UK. | Q36612234 | ||
| Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis | Q36914874 | ||
| Purposeful selection of variables in logistic regression | Q37077675 | ||
| Psoriasis severity and the prevalence of major medical comorbidity: a population-based study | Q37239394 | ||
| Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. | Q37248193 | ||
| Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia | Q37282686 | ||
| Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients. | Q37286386 | ||
| From the Medical Board of the National Psoriasis Foundation: Vaccination in adult patients on systemic therapy for psoriasis | Q38146025 | ||
| British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017. | Q39312849 | ||
| Psoriasis is associated with increased beta-defensin genomic copy number | Q39789019 | ||
| The Read clinical classification | Q43175398 | ||
| Increased risk of infectious disease requiring hospitalization among patients with psoriasis: a population-based cohort | Q44745984 | ||
| Advisory committee on immunization practices recommended immunization schedules for persons aged 0 through 18 years--United States, 2015. | Q53809134 | ||
| Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older--United States, 2015. | Q53985983 | ||
| Risk of Myocardial Infarction in Patients With Psoriasis | Q60711909 | ||
| Impairment of antibacterial defense mechanisms of the lung by extrapulmonary infection | Q68859119 | ||
| Intraportal lipopolysaccharide suppresses pulmonary antibacterial defense mechanisms | Q73851406 | ||
| P433 | issue | 8 | |
| P921 | main subject | herpes zoster | Q182155 |
| opportunistic infection | Q835718 | ||
| P304 | page(s) | 1726-1735 | |
| P577 | publication date | 2018-03-02 | |
| P1433 | published in | Journal of Investigative Dermatology | Q3186921 |
| P1476 | title | Risk of Serious Infection, Opportunistic Infection, and Herpes Zoster among Patients with Psoriasis in the United Kingdom | |
| P478 | volume | 138 |
| Q89941551 | A Case of Psoriasis Vulgaris Treated with Brodalumab in a Hemodialysis Patient with End-Stage Renal Disease due to Diabetic Nephropathy |
| Q57478504 | Influenza Vaccination Rates in Adults with Psoriasis Compared to Adults with Other Chronic Diseases |
| Q91918052 | Risk of Serious Infection in Patients Receiving Systemic Medications for the Treatment of Psoriasis |
Search more.